ArticleJournal of nanobiotechnology2022

ROS-responsive liposomes as an inhaled drug delivery nanoplatform for idiopathic pulmonary fibrosis treatment via Nrf2 signaling.

Junzhao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.